Category: Niger
-
Updates from the field – AVENIR II in November
—
published by
AVENIR II in Niger – November 2024 November saw the successful completion of a number of activities, including the continued mass distribution of azithromycin in the Dosso and Tahoua regions. […]
-
AVENIR II in September 2024
September was a busy month for AVENIR, with activities ranging from training courses to meetings with health and district authorities. Preparations for AVENIR II in Zinder With the second phase […]
-
REACH Network annual meeting leads to historic Abuja Declaration
—
published by
African leaders and global health partners commit to saving children’s lives in Africa The Co-chairs of the Resiliency through Azithromycin for Children (REACH) Network, Coordinating Minister of Health and Social […]
-
REACH Niger publishes important results demonstrating efficacy of azithromycin in reducing child mortality
Writing in the prestigious New England Journal of Medicine, the AVENIR study group demonstrate that distributing azithromycin twice a year to children aged 1 to 59 months significantly reduced mortality and that including older children in treatment was more effective than targeting infants aged 1 to 11 months only.
-
Updates from the AVENIR project in Niger – August 2024
The “Azithromycine pour la Vie des Enfants au Niger” (“Azithromycin to Save the Lives of Children in Niger”) project, known as AVENIR, continues to make significant progress in reducing child mortality and morbidity in Niger. […]
-
AVENIR project updates, July 2024
A growing intervention The second phase of the AVENIR project is getting underway in the Dosso region of Niger during the fourth quarter of 2024. In preparation for this intervention, […]
-
Azithromycin for child survival in Niger – implementation and research
Under the patronage of the Minister of Public Health, Population and Social Affairs, Niger launched the second phase of the AVENIR project on Tuesday, 19 March 2024. The official ceremony […]